Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetes

被引:21
|
作者
Bracken, R. M. [1 ,2 ]
West, D. J. [1 ,2 ]
Stephens, J. W. [2 ]
Kilduff, L. P. [1 ]
Luzio, S. [3 ]
Bain, S. C. [2 ]
机构
[1] Swansea Univ, Sports & Exercise Sci Res Ctr, Sch Engn, Swansea SA2 8PP, W Glam, Wales
[2] Swansea Univ, Diabet Res Grp, Sch Med, Swansea SA2 8PP, W Glam, Wales
[3] Univ Wales Hosp, Ctr Endocrine & Diabet Sci, Diabet Res Unit, Cardiff CF4 4XW, S Glam, Wales
关键词
acid-base balance; carbohydrate supplementation; exercise; ketoacidosis; EXERCISE; LISPRO; HYPOGLYCEMIA; ASPART;
D O I
10.1111/j.1464-5491.2010.03162.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Aim This study examined the effects of reductions to pre-exercise rapid-acting insulin dose on changes in blood beta-hydroxybutyrate, glucose, acid-base balance and counter-regulatory hormone responses to prolonged running in individuals with Type 1 diabetes. Methods Following ethical approval, seven participants with Type 1 diabetes (34 +/- 2 years, BMI 27 +/- 1 kg/m2) completed this study. After preliminary testing, participants attended the laboratory four times, each time consuming a 1.12MJ meal (60 g carbohydrate, 2 g fat, 2 g protein), with randomized amounts of their rapid-acting insulin: Full dose (mean 7.3 +/- 0.2 units), 75% dose (mean 5.4 +/- 0.1 units), 50% dose (mean 3.7 +/- 0.1 units) or 25% dose (mean 1.8 +/- 0.1 units). After 2-h rest, participants completed 45 min running at 70 +/- 1% peak rate of oxygen consumption (VO(2peak)). Blood metabolites and hormones were recorded over the 2-h rest and 3-h recovery. Data were analysed using repeated-measures ANOVA. Results Serum insulin peaked at 60 min in all conditions and was lowest after 25% insulin dose compared with full dose (P = 0.03). After the 25% insulin dose immediately pre-exercise glucose concentration was higher than after the full or 50% dose (P < 0.05). Resting beta-hydroxybutyrate gradually decreased during 2-h rest (P < 0.05) with a similar post-exercise peak of beta-hydroxybutyrate at 3 h (P > 0.05). Post-exercise blood pH increased for 5 min to a similar extent with all insulin doses , but the rise with the 25% dose was less compared with the full dose (P = 0.01). Blood lactate and plasma catecholamines increased after running similarly with all insulin reduction conditions (P < 0.05). Blood glucose area under the curve (BG(auc)) after the 25% insulin dose was greater than after the 75% dose (P = 0.02). Conclusion Ketogenesis following running was not influenced by reductions in pre-exercise rapid-acting insulin dose. This important preparatory strategy aids preservation of blood glucose but poses no greater risk to exercise-induced ketone body formation.
引用
收藏
页码:218 / 222
页数:5
相关论文
共 50 条
  • [1] Blood glucose responses to reductions in pre-exercise rapid-acting insulin for 24h after running in individuals with type 1 diabetes
    West, Daniel J.
    Morton, Richard D.
    Bain, Stephen C.
    Stephens, Jeffrey W.
    Bracken, Richard M.
    JOURNAL OF SPORTS SCIENCES, 2010, 28 (07) : 781 - 788
  • [2] Rapid-acting insulin approved for type 1 and type 2 diabetes mellitus
    不详
    NURSE PRACTITIONER, 2020, 45 (11): : 56 - 56
  • [3] The preservation of glycaemia through large pre- and post-exercise rapid-acting insulin reductions prevents early, but not late-onset hypoglycaemia in individuals with Type 1 diabetes
    Campbell, M. D.
    Walker, M.
    Trenell, M. I.
    Stevenson, E. J.
    Jakovljevic, D. G.
    Bracken, R. M.
    Bain, S. C.
    Turner, D.
    West, D. J.
    DIABETIC MEDICINE, 2013, 30 : 9 - 9
  • [4] Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial
    Campbell, Matthew D.
    Walker, Mark
    Trenell, Michael I.
    Luzio, Steven
    Dunseath, Gareth
    Tuner, Daniel
    Bracken, Richard M.
    Bain, Stephen C.
    Russell, Mark
    Stevenson, Emma J.
    West, Daniel J.
    PLOS ONE, 2014, 9 (05):
  • [5] Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus
    Fiallo-Scharer, Rosanna
    Horner, Brian
    McFann, Kim
    Walravens, Philippe
    Chase, H. Peter
    JOURNAL OF PEDIATRICS, 2006, 148 (04): : 481 - 484
  • [6] Self-reported glycaemic changes following individualised rapid-acting insulin dose after morning resistance exercise in Type 1 diabetes
    McCarthy, O. M.
    Prior, S. L.
    Churm, R. C.
    Thomas, R. L.
    Turner, D.
    Bain, S. C.
    Bracken, R. M.
    DIABETIC MEDICINE, 2017, 34 : 73 - 73
  • [7] Pharmacokinetics of a rapid-acting human insulin analogue, insulin aspart, in children and adolescents with type 1 diabetes
    Mortensen, H
    Olsen, B
    Li'ndholm, A
    DIABETES, 1999, 48 : A358 - A358
  • [8] Rapid-acting insulin analogues: Theory and best clinical practice in type 1 and type 2 diabetes
    De Block, Christophe E. M.
    Van Cauwenberghe, Jolijn
    Bochanen, Niels
    Dirinck, Eveline
    DIABETES OBESITY & METABOLISM, 2022,
  • [9] Large Pre- and Postexercise Rapid-Acting Insulin Reductions Preserve Glycemia and Prevent Early- but Not Late-Onset Hypoglycemia in Patients With Type 1 Diabetes
    Campbell, Matthew D.
    Walker, Mark
    Trenell, Michael I.
    Jakovljevic, Djordje G.
    Stevenson, Emma J.
    Bracken, Richard M.
    Bain, Stephen C.
    West, Daniel J.
    DIABETES CARE, 2013, 36 (08) : 2217 - 2224
  • [10] Efficacy of Rapid-Acting and Long-Acting Insulin Analogs in Japanese Patients with Type 1 Diabetes Mellitus
    Ozaki, Nobuaki
    Nomura, Yoshio
    Wanibe, Harumatsu
    Yamamori, Ikuo
    Oiso, Yutaka
    DIABETES, 2009, 58 : A524 - A524